Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Pediatric Hematology/Oncology
•
Leukemia
•
AYA
•
Hematology
•
AYA Cancers
How do you preserve fertility in women with newly diagnosed acute leukemia?
Related Questions
In what situations do you use G-CSF for patients undergoing allogeneic HSCT to facilitate engraftment?
For AML patients, when do you stop antiinfective agents?
How would you treat a patient with Hodgkin lymphoma who has an isolated relapse within the CNS?
Does the presence of asparaginase antibodies on Granger Genetics testing indicate need to switch asparaginase formulations?
Would you offer intensive CNS prophylaxis to Ph negative B-ALL patients who have possible mandibular nerve involvement on MRI face?
What is your current approach to maintenance therapy in FLT3-mutant AML post allogeneic HCT?
What is the preferred approach for an AYA patient with VHR B-ALL with iAMP21 mutation with an isolated early CNS relapse?
How do you incorporate blinatumomab into therapy for a pediatric or AYA patient with isolated CNS relapse of B-ALL, if at all?
What is your approach to re-challenging BTK inhibitors for a patient who has had intolerance to several different agents?
How would you manage a young, HIV-negative patient with good performance status with primary refractory Burkitt Lymphoma involving the CNS and systemic disease?
